Express Scripts balances clinical efficacy, costs with revised formulary

10/18/2013 | Pharmalot

Express Scripts excluded 48 drugs from its formulary based on lack of clinical efficacy or cost effectiveness as well as drugmakers' use of co-pay cards, says Chief Medical Officer Steven Miller. "As there are more products in the marketplace that are interchangeable, we'll do more to seek the best value for our members," Miller said.

View Full Article in:

Pharmalot